These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 21906736)

  • 21. Uric acid is independent cardiovascular risk factor, as manifested by increased carotid intima-media thickness in rheumatoid arthritis patients.
    Hannawi S; AlSalmi I; Moller I; Naredo E
    Clin Rheumatol; 2017 Aug; 36(8):1897-1902. PubMed ID: 28664292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Sabio JM; Vargas-Hitos J; Zamora-Pasadas M; Mediavilla JD; Navarrete N; Ramirez A; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J;
    J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
    Bruce IN
    Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum cystatin C is associated with kidney function but not with cardiovascular risk factors or subclinical atherosclerosis in patients with Systemic Lupus Erythematosus.
    Garcia-Garcia P; Castejon R; Tutor-Ureta P; Silvestre RA; Mellor-Pita S; Jimenez-Ortiz C; Yebra-Bango M
    Clin Rheumatol; 2017 Dec; 36(12):2709-2717. PubMed ID: 28914371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular risk profile in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of female patients.
    Santos MJ; Vinagre F; Silva JJ; Gil V; Fonseca JE
    Acta Reumatol Port; 2010; 35(3):325-32. PubMed ID: 20975635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased arterial stiffness is independently associated with metabolic syndrome and damage index in systemic lupus erythematosus patients.
    Valero-Gonzalez S; Castejon R; Jimenez-Ortiz C; Rosado S; Tutor-Ureta P; Vargas JA; Yebra-Bango M
    Scand J Rheumatol; 2014; 43(1):54-8. PubMed ID: 24050535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subclinical Atherosclerosis in Systemic Sclerosis: Not Less Frequent Than Rheumatoid Arthritis and Not Detected With Cardiovascular Risk Indices.
    Ozen G; Inanc N; Unal AU; Korkmaz F; Sunbul M; Ozmen M; Akar S; Deniz R; Donmez S; Pamuk ON; Atagunduz P; Tigen K; Direskeneli H
    Arthritis Care Res (Hoboken); 2016 Oct; 68(10):1538-46. PubMed ID: 26866424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated blood viscosity in systemic lupus erythematosus.
    Rosenson RS; Shott S; Katz R
    Semin Arthritis Rheum; 2001 Aug; 31(1):52-7. PubMed ID: 11503139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocan Levels and Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus.
    Icli A; Cure E; Cure MC; Uslu AU; Balta S; Mikhailidis DP; Ozturk C; Arslan S; Sakız D; Sahin M; Kucuk A
    Angiology; 2016 Sep; 67(8):749-55. PubMed ID: 26614790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subclinical atherosclerosis among rheumatoid arthritis patients without overt cardiovascular risk factors.
    Sahari NS; Shaharir SS; Ismail MR; Rajalingham S; Mohamed Said MS
    Mod Rheumatol; 2014 Nov; 24(6):920-5. PubMed ID: 24645724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early phase clinical and biological markers associated with subclinical atherosclerosis measured at 7 years of evolution in an early inflammatory arthritis cohort.
    Vandhuick T; Allanore Y; Borderie D; Louvel JP; Fardellone P; Dieudé P; Goëb V; Clavel G; Boissier MC; Jouen F; Boumier P; Allart JD; Mejjad O; Pouplin S; Jan M; Ménard JF; Le Loët X; Vittecoq O
    Clin Exp Rheumatol; 2016; 34(1):58-67. PubMed ID: 26744355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemorheological alterations in carotid artery stenosis.
    Totsimon K; Nagy A; Sandor B; Biro K; Csatho A; Szapary L; Toth K; Marton Z; Kenyeres P
    Clin Hemorheol Microcirc; 2016 Nov; 64(1):55-63. PubMed ID: 26890237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations of haemorheological parameters in patients with peripheral arterial disease.
    Ricci I; Sofi F; Liotta AA; Fedi S; Macchi C; Pratesi G; Pulli R; Pratesi C; Abbate R; Mannini L
    Clin Hemorheol Microcirc; 2013 Jan; 55(2):271-6. PubMed ID: 23089883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum pentraxin 3 and interleukin-6 are associated with subclinical atherosclerosis in recent-onset rheumatoid arthritis.
    Mabrouk MM; Ghazy MA; Hassan TM
    Egypt J Immunol; 2010; 17(1):87-99. PubMed ID: 22053612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired Hemorheological Parameters and Increased Carotid Intima-Media Thickness in Children with Subclinical Hypothyroidism.
    Isik-Balci Y; Agladioglu S; Agladioglu K; Kilic-Toprak E; Kilic-Erkek O; Ozhan B; Polat A; Bor-Kucukatay M
    Horm Res Paediatr; 2016; 85(4):250-6. PubMed ID: 26934063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Higher circulating levels of OxLDL % of LDL are associated with subclinical atherosclerosis in female patients with systemic lupus erythematosus.
    Ahmad HM; Sarhan EM; Komber U
    Rheumatol Int; 2014 May; 34(5):617-23. PubMed ID: 24101173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of lipids and obesity on haemorheological parameters in patients with deep vein thrombosis.
    Vayá A; Falcó C; Simó M; Ferrando F; Mira Y; Todolí J; España F; Corella D
    Thromb Haemost; 2007 Sep; 98(3):621-6. PubMed ID: 17849051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atherogenic Index of Plasma in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus: A 10-Year Potential Predictor of Cardiovascular Disease.
    Hammam N; Abdel-Wahab N; Gheita TA
    Curr Rheumatol Rev; 2021; 17(1):122-130. PubMed ID: 33030132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and factors associated with metabolic syndrome in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Zonana-Nacach A; Santana-Sahagún E; Jiménez-Balderas FJ; Camargo-Coronel A
    J Clin Rheumatol; 2008 Apr; 14(2):74-7. PubMed ID: 18391674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subclinical atherosclerosis in patients with systemic lupus erythematosus: A systemic review and meta-analysis.
    Wu GC; Liu HR; Leng RX; Li XP; Li XM; Pan HF; Ye DQ
    Autoimmun Rev; 2016 Jan; 15(1):22-37. PubMed ID: 26455562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.